Our Science
December 8, 2025
The Future of Medicine is in Our Genes
Additional human genetics data partnerships are helping scientists identify new drug targets, improving the chances of developing effective medicines
Read More ›
September 30, 2025
How Alnylam’s Manufacturing Investments Bring RNAi Therapeutics to More Patients, Faster
Translating our pioneering work in RNAi not only requires innovation in the lab - it requires innovation in how we make our medicines.
Read More ›
August 26, 2025
RNAi Therapeutics: 5 Things You Should Know about this Innovative Class of Medicines
What is RNAi and what do RNAi therapeutics do? Here are 5 things you should know!
Read More ›
February 21, 2025
A New Therapeutic Approach Seeks to Silence Devastating Neurological Diseases
Exploring the potential of RNAi therapeutics to tackle brain diseases with few or no treatments
Read More ›
September 26, 2024
Confronting the World’s Leading Killer with a New Therapeutic Approach
For Xicang Guo and Jiaming Zhang, one particular condition remains stubbornly beyond their control – hypertension, also known as high blood pressure.
Read More ›
September 12, 2024
RNAi Therapeutics, from Possibility to Patients
The story of an innovative approach to silencing disease that’s improving lives and changing expectations for medicine.
Read More ›
October 1, 2019
Building for Our Future
Why would a company without a commercially approved medicine decide to build a significant manufacturing facility? Why not continue to rely on contract...
Read More ›
April 30, 2018
Hunting for Targets: Bringing RNAi to Humans
Evolution is a powerful force, and Mother Nature is often a great source of inspiration for drug hunters like me. If you look at the history of successful...
Read More ›
April 30, 2018
Building to Scale: Raising RNAi Therapeutics From Infancy
When I joined Alnylam in 2004, one of our early challenges was figuring out how to manufacture and deliver RNAi therapeutics for our clinical trials. The...
Read More ›
February 28, 2018
Harnessing the Power of RNAi™: Pushing Through the Challenges and Setbacks
I am an organic chemist, and what keeps me going after 3 decades working in the field of oligonucleotides is transforming complex chemistry into medicines...
Read More ›
